Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Intravenous Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

NCT01747499 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01747499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01747499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Intravenous Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation
Lead sponsor
Washington University School of Medicine
Phase
Phase 1/2
Overall status
Terminated
Start date
April 15, 2013
Completion date
December 24, 2018
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myeloid, acute, myelodysplastic syndromes, precursor cell lymphoblastic leukemia-lymphoma